Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Elementary Particles”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 433 records · Page 24Linked to original sources
PubMedDate not supplied

A Monte Carlo program for photon transport using analogue sampling of scattering angle in coherent and incoherent scattering processes.

A computer program was developed for the Monte Carlo simulation of photon transport. The program was designed for photon transport simulation in geometries occurring in diagnostic radiology and especially for the investigation of scattered radiation. A method is described for the analogue sampling of scattering angle in coherent and incoherent scattering processes. The two scattering processes are treated separately, and the influence of coherent scattering, an often neglected process, can be estimated quantitatively. The program can also be used for the calculation of the energy imparted to water slabs and fluorescent screens.

Computers↗
PubMed1975

Cuprodoxin.

Explore the source record for details and available documents.

Amino Acids↗
PubMed1990

Preclinical evaluation of pions in vivo: experience at TRIUMF.

This paper describes the results obtained from in vivo studies of the pion beam at the TRI University Meson Facility (TRIUMF). The studies encompass work (from 1978 to 1986), designed to evaluate the RBE for early and late effects and to assess the importance of X-ray dose rate and treatment volume on these values. Results with early responding tissues, i.e. mouse and pig skin and mouse intestine indicate a pion RBE of about 1.5 in the clinically relevant dose per fraction range of 2-3 Gy. At these doses, RBE appears to be independent of the reference X-ray dose rate. However, at high doses per fraction, the RBE values become increasingly X-ray dose rate dependent. The induction of late effects by pions has been assessed by monitoring the late dermal response of pig skin; late fibrosis was not assessed in this study. The values obtained using the chosen endpoint indicate that the RBE is not significantly higher than that seen in any of the early responding tissues for pion doses as low as 2-3 Gy per fraction. The effect of increasing the treatment volume for pion therapy has been assessed using mouse intestine. The results show that for a constant field size, RBE decreases with increasing peak width. However, if peak width is held constant and field size increased, there is evidence for an increased RBE.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1990

Pion therapy at TRIUMF. Treatment results for astrocytoma grades 3 and 4: a pilot study.

At TRIUMF, (located on the University of B.C. Campus), 53 patients with supratentorial astrocytoma grades 3 and 4 were treated with pions between 1982 and 1985. A 3-dimensional spot-scanning treatment technique has proven to be practical. The accuracy of the beam alignment system used for treatment was reproducible daily within 2 mm. Low pion flux has hindered optimal beam shaping but this will soon be remedied as flux improves. The overall median survival observed (53 patients) is 262 days from date of first radiation treatment. Younger (less than 49 years) patients have significantly better survival than older (greater than 50 years) patients (p = 0.001). From a base line dose of 40 Gy photons whole brain and 17.5 Gy pion boost, doses were escalated to 33 Gy pions localised to the primary tumour and the median survival improved from 198 to 436 days. Survival curves for patients treated with localised pion techniques to doses above 30 Gy are significantly better than for those treated with schedules of pions mixed with photons (p = 0.04). It appears that optimal pion dose for brain tumours is 33 Gy minimum with a possible maximum of 36 Gy and doses delivered in 15 fractions in 3 weeks. Requirements for future trials are discussed.

Adult↗
PubMed1987

The Diogene 4 pi detector at Saturne.

Diogene, an electronic 4 pi detector, has been built and installed at the Saturne synchrotron in Saclay. The forward angular range (0 degree-6 degrees) is covered by 48 time-of-flight scintillator telescopes that provide charge identification. The trajectories of fragments emitted at larger angles are recorded in a cylindrical 0.4-m3 Pictorial Drift Chamber (PDC) surrounding the target. The PDC is inside a 1-T magnetic field; the axis of the PDC cylinder and the magnetic field are parallel to the beam. Good identification has been obtained for both positive and negative pi mesons and for hydrogen and helium isotopes. Multiplicities in relativistic nucleus-nucleus reactions up to 40 have been detected, limited mainly by the present electronics.

Elementary Particles↗
PubMed1984

LET-distributions and doses of HZE radiation components at near-Earth orbits.

Among cosmic rays, the heavy nuclei ranging from carbon to iron provide the principal contribution to the dose equivalent. The LET-distributions and absorbed dose aid dose equivalent have been calculated and are presented as a function of shielding and tissue self-shielding. At solar minimum, outside the magnetosphere, the unshielded dose equivalent of nuclei with atomic number Z > or = 6 is about 47 rem/year. The contribution of the target nuclei adds 7 rem/year. With 4 g/cm2 aluminum shielding, and at a depth of 5 cm in a biological phantom of 30 cm diameter, the respective values are 11 and 10 rem/year. Corresponding dose rates for orbits with various inclinations are presented, as well as the LET distributions of various components of cosmic rays.

Cosmic Radiation↗